Who cares about the obese hypertensive patient?

Journal of Internal Medicine

Volumn 251, Issue 5, 2002, Pages 369-371

  Sharma, A M ^a   Rossner S ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXAZOSIN; GANGLION BLOCKING AGENT; METHYLDOPA; RAUWOLFIA ALKALOID;

CARDIOVASCULAR RISK; COMORBIDITY; DIET; DRUG METABOLISM; EDITORIAL; HUMAN; HYPERTENSION; LIVER DISEASE; OBESITY; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL;

HUMANS; HYPERTENSION; OBESITY;

EID: 0036094494     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2002.00982.x     Document Type: Editorial

References (16)

1. Splanchniectomy for essential hypertension. Results in 1266 cases
2. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991
3. Choice of drug treatment for obesity-related hypertension: Where is the evidence?
4. Hypothesis: Beta-adrenergic receptor blockers and weight gain. A systematic analysis
5. Glucose tolerance during antihypertensive therapy in patients with diabetes mellitus
6. National Heart, Lung, and Blood Institute halts part of antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
7. Clonidine in patients with diabetes and mild hypertension
8. WHO technical report series
9. Overweight and obesity: A global problem requires practical tools
10. Obesity: Impact on cardiovascular disease
11. AHA dietary guidelines: Revision 2000. A statement for healthcare professionals from the Nutrition Committee of the American Heart Association
12. Obesity in the elderly - A future matter of concern?
13. Managing big issues on lean evidence or treating obesity hypertension